Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response
About this item
Full title
Author / Creator
Okamoto, Yuji , Hirano, Mitsuhito , Morino, Kai , Kajita, Masashi K. , Nakaoka, Shinji , Tsuda, Mayuko , Sugimoto, Kei-ji , Tamaki, Shigehisa , Hisatake, Junichi , Yokoyama, Hisayuki , Igarashi, Tadahiko , Shinagawa, Atsushi , Sugawara, Takeaki , Hara, Satoru , Fujikawa, Kazuhisa , Shimizu, Seiichi , Yujiri, Toshiaki , Wakita, Hisashi , Nishiwaki, Kaichi , Tojo, Arinobu and Aihara, Kazuyuki
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Chronic myeloid leukemia (CML) is a myeloproliferative disorder caused by the
BCR-ABL1
tyrosine kinase. Although
ABL1
-specific tyrosine kinase inhibitors (TKIs) including nilotinib have dramatically improved the prognosis of patients with CML, the TKI efficacy depends on the individual patient. In this work, we found that the patients...
Alternative Titles
Full title
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response
Authors, Artists and Contributors
Author / Creator
Hirano, Mitsuhito
Morino, Kai
Kajita, Masashi K.
Nakaoka, Shinji
Tsuda, Mayuko
Sugimoto, Kei-ji
Tamaki, Shigehisa
Hisatake, Junichi
Yokoyama, Hisayuki
Igarashi, Tadahiko
Shinagawa, Atsushi
Sugawara, Takeaki
Hara, Satoru
Fujikawa, Kazuhisa
Shimizu, Seiichi
Yujiri, Toshiaki
Wakita, Hisashi
Nishiwaki, Kaichi
Tojo, Arinobu
Aihara, Kazuyuki
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_58f4e055c3eb45ed81510406b1170155
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_58f4e055c3eb45ed81510406b1170155
Other Identifiers
ISSN
2056-7189
E-ISSN
2056-7189
DOI
10.1038/s41540-022-00248-3
